Dr Joaquim Bellmunt from the Beth Israel Deaconess Medical Center in Boston discusses the use of immune checkpoint inhibitors in urothelial bladder carcinoma.

CME information and select publications here.

Dr David O’Malley from the Ohio State University and The James Cancer Center in Columbus discusses the current and future roles of immune checkpoint inhibitors and other novel therapies in the management of gynecologic cancers.

CME information and select publications here.

Dr Andrew Ko from the University of California, San Francisco discusses recently published and emerging research in the management of pancreatic cancer.

CME information and select publications here.

Dr Philip A Philip from the Karmanos Cancer Institute in Detroit, Michigan, discusses recent data sets in gastrointestinal cancers from the ASCO and ESMO 2020 meetings that are most likely to have an impact on clinical practice.

Faculty information and select publications here.

Dr Sylvia Adams from the Perlmutter Cancer Center in New York discusses recently published and emerging research on the use of immune checkpoint inhibition in breast cancer.

CME information and select publications here.

Dr Eric Klein from the Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio, discusses the role of liquid biopsy for cancer detection, including his experience with the Circulating Cell-Free Genome Atlas study.

Faculty information and select publications here.

Dr Peter Voorhees from the Levine Cancer Institute in Charlotte, North Carolina, discusses novel agents under investigation in multiple myeloma.

CME information and select publications here.

Professor Stephen Johnston from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London discusses the role of CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer.

CME information and select publications here.

Dr Ross Camidge from the University of Colorado in Denver discusses recently published and emerging research in the management of non-small cell lung cancer with ALK and ROS1 rearrangements.

CME information and select publications here.

Dr Daniel Catenacci from the University of Chicago Medicine and Biological Sciences discusses recently published and emerging research in the management of gastroesophageal cancers.

CME information and select publications here.